{"url_path":"/sec/rgbpp/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 Quantitative and Qualitative Disclosures About Market Risk**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1589150/0001493152-26-022924-index.html","accession_number":"0001493152-26-022924","cik":"0001589150","ticker":"RGBP","issuer_name":"Regen BioPharma Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1589150/0001493152-26-022924-index.html","primary_entity_key":"0001589150","primary_entity_name":"Regen BioPharma Inc"},"word_count":71,"has_tables":true,"body_markdown":"**Item\n3. Quantitative and Qualitative Disclosures About Market Risk**\n\n \n\nAs\na smaller reporting company, as defined by Rule 229.10(f) (1) of Regulation S-K, we are not required to provide the information required\nby this Item. We have chosen to disclose, however, that we have not engaged in any transactions, issued or bought any financial instruments\nor entered into any contracts that are required to be disclosed in response to this item."}